Advanced search
Publication Cover
Journal of Asthma and Allergy Volume 15, 2022 - Issue
Submit an article Journal homepage
146
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Annual and Post-Exacerbation Follow-Up of Asthma Patients in Clinical Practice – A Large Population-Based Study in Sweden

Hanna Sandelowsky1 Karolinska Institutet, Department of Medicine, Division of Clinical Epidemiology, Solna, Sweden;2 Karolinska Institutet, Department of Neurobiology, Care Sciences and Society, Division of Family Medicine and Primary Care, Solna, Sweden;3 Academic Primary Health Care Centre, Region Stockholm, SwedenCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-1721-6540View further author information
ORCID Icon,
Björn Ställberg4 Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, SwedenORCID Iconhttps://orcid.org/0000-0001-8497-7326View further author information
ORCID Icon,
Fredrik Wiklund5 Statisticon AB, Uppsala, SwedenORCID Iconhttps://orcid.org/0000-0001-7271-7092View further author information
ORCID Icon,
Gunilla Telg6 AstraZeneca Nordic, Södertälje, SwedenORCID Iconhttps://orcid.org/0000-0002-1391-7446View further author information
ORCID Icon,
Sofie de Fine Licht6 AstraZeneca Nordic, Södertälje, SwedenORCID Iconhttps://orcid.org/0000-0001-7855-4706View further author information
ORCID Icon &
Christer Janson7 Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, SwedenORCID Iconhttps://orcid.org/0000-0001-5093-6980View further author information
ORCID Icon
Pages 475-486 | Published online: 13 Apr 2022

Figures & data

Table 1 Baseline Characteristics of Study Population

Table 2 Asthma Follow-Up Visits During 15 Months After Index and 15 Months After an Exacerbation, by Type of Visit

Figure 1 Probability of having an asthma follow-up visit within 15 months after index date*.

Note: Patients are censored at time of first moderate or severe exacerbation.
Figure 1 Probability of having an asthma follow-up visit within 15 months after index date*.

Table 3 Respiratory Related Medications During 15 Months Following Index

Figure 2 Probability of having an asthma follow-up visit within 15 months after an exacerbation, by type of index exacerbation and type of follow-up visit.

Note: Patients are censored at time of second moderate or severe exacerbation.
Figure 2 Probability of having an asthma follow-up visit within 15 months after an exacerbation, by type of index exacerbation and type of follow-up visit.

Figure 3 Proportion of patients with 1, 2, 3, ≥4 claims of ICS* at pharmacy during 15 months follow-up after index, stratified by (A) calendar period of inclusion; 2006–2009, 2010–2013, 2014–2017 as well as (B) the full follow-up period 2006–2017.

Notes: ICS collection at pharmacy includes both mono- and combination treatment.
Abbreviation: ICS, inhaled corticosteroid.
Figure 3 Proportion of patients with 1, 2, 3, ≥4 claims of ICS* at pharmacy during 15 months follow-up after index, stratified by (A) calendar period of inclusion; 2006–2009, 2010–2013, 2014–2017 as well as (B) the full follow-up period 2006–2017.

Figure 4 Probability of having an asthma follow-up visit at 15 months after index date and after first exacerbation, by calendar year of inclusion.

Figure 4 Probability of having an asthma follow-up visit at 15 months after index date and after first exacerbation, by calendar year of inclusion.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.